Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on April 11, 2025

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024

Châtillon, France, le 11 avril 2025 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique au stade clinique …

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today …

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to redefining the retina experience, today announced that it has granted inducement awards to its newly appointed …

Signing Day Sports Provides Announcement on 2024 Annual Report

Signing Day Sports Provides Announcement on 2024 Annual Report

SCOTTSDALE, Ariz., April 11, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform to aid high school athletes in the recruitment process, …

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") announced today that, pursuant to a securities purchase agreement (the “Purchase Agreement”) with Blue Harbour Asset Management L.L.C-FZ (“ …

ParaZero Announces Receipt of Nasdaq Minimum Bid Price Notification

ParaZero Announces Receipt of Nasdaq Minimum Bid Price Notification

TEL AVIV, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace company focused on safety systems for commercial unmanned aerial systems and counter UAS systems, today announced it …

Hubbell to Announce First Quarter 2025 Results on May 1, 2025

Hubbell to Announce First Quarter 2025 Results on May 1, 2025

Shelton, CT, April 11, 2025 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced it will release its first quarter 2025 financial results prior to the opening of the market on May 1st, 2025. The Company will then webcast its Analysts' …

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Polyrizon Receives Nasdaq Notification Regarding Minimum Bid Requirements

Raanana, Israel, April 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that on April 8, 2025, …

Beam Global Reports Full Year 2024 Operating Results

Beam Global Reports Full Year 2024 Operating Results

SAN DIEGO, April 11, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation, smart cities, and energy security, today …

4DMT Announces New Employment Inducement Grants

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment …

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

CANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

argenx Announces Annual General Meeting of Shareholders on May 27, 2025

argenx Announces Annual General Meeting of Shareholders on May 27, 2025

April 11, 2025, 10:01 PM CET Amsterdam, the Netherlands – argenx SE (Euronext …

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WOBURN, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the grant of inducement equity awards to newly …

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases, today announced that on April 9, 2025, the compensation …

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next frontier …

iOThree Limited Announces Closing of Initial Public Offering

iOThree Limited Announces Closing of Initial Public Offering

SINGAPORE, April 11, 2025 (GLOBE NEWSWIRE) -- iOThree Limited ("iOThree" or the "Company") (NASDAQ: IOTR), a leading provider of maritime digital technologies including satellite connectivity and digitalization solutions in Singapore with a focus on …

Military Shelters Market is Forecasted to Reach US$ 1,473 Million in 2031, Says Stratview Research

Military Shelters Market is Forecasted to Reach US$ 1,473 Million in 2031, Says Stratview Research

Detroit, April 11, 2025 (GLOBE NEWSWIRE) -- The global Military Shelters Market is projected to witness a growth rate of 3.5% annually from 2025 to 2031, with an anticipated size of US$ 1,473 million by 2031, according to an analysis by Stratview Research. …

Aircraft Propulsion Composite Blades Market is Forecasted to Reach US$ 480 Million in 2030, Says Stratview Research

Aircraft Propulsion Composite Blades Market is Forecasted to Reach US$ 480 Million in 2030, Says Stratview Research

Detroit, April 11, 2025 (GLOBE NEWSWIRE) -- The global aircraft propulsion composite blades market is projected to witness a growth rate of >3% annually from 2025 to 2030, with an anticipated size of US$ 480 million by 2030, according to an analysis by …

Aircraft Specialty Fasteners Market is Forecasted to Reach US$ 1200 Million in 2032, Says Stratview Research

Aircraft Specialty Fasteners Market is Forecasted to Reach US$ 1200 Million in 2032, Says Stratview Research

Detroit, April 11, 2025 (GLOBE NEWSWIRE) -- The global aircraft specialty fasteners market is projected to witness a growth rate of 4.4% annually from 2024 to 2032, with an anticipated size of US$ 1200 million by 2032, according to an analysis by Stratview …

Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns

Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns

Board Timed Highly Dilutive Financing to Close on the Record Date for the Annual Meeting, Tilting the Vote and Forcing the Withdrawal of the Restore Value Slate Second Major Transaction in Six Months Undertaken Without Stockholder Input with Significant …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service